Human tyrosinase is able to oxidize both enantiomers of rhododendrol

Authors:

Abstract
Summary: RacemicRS‐4‐(4‐hydroxyphenyl)‐2‐butanol (rhododendrol,RD) was used as a topical skin‐whitening agent until it was recently reported to induce leukoderma. We then showed that oxidation ofRDwith mushroom tyrosinase rapidly producesRD‐quinone, which is quickly converted toRD‐cyclic quinone andRD‐hydroxy‐p‐quinone. In this study, we examined whether either or both of the enantiomers ofRDcan be oxidized by human tyrosinase. Using a chiralHPLCcolumn, racemicRDwas resolved optically toR(−)‐RDandS(+)‐RDenantiomers. In the presence of a catalytic amount ofl‐dopa, human tyrosinase, which can oxidizel‐tyrosine but notd‐tyrosine, was found to oxidize bothR(−)‐ andS(+)‐RDto giveRD‐catechol and its oxidation products.S(+)‐RDwas more effectively oxidized thanl‐tyrosine, whileR(−)‐RDwas less effective. These results support the notion that the melanocyte toxicity ofRDdepends on its tyrosinase‐catalyzed conversion to toxic quinones and the concomitant production of reactive oxygen species.
Funding Information
  • Japanese Society for the Promotion of Science (23591659, 26461705)

This publication has 15 references indexed in Scilit: